Sutro Biopharma Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in TF-Expressing Solid Tumors

Sutro Biopharma Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in TF-Expressing Solid Tumors GlobeNewswire December 03, 2025 – Initial clinical data expected mid-2026 – SOUTH SAN FRANCISCO, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical […]

Officially Licensed Mutant Football League Merchandise from Bull Airs Brings Monstrous Mayhem to the Masses

Officially Licensed Mutant Football League Merchandise from Bull Airs Brings Monstrous Mayhem to the Masses Sneakers, Clothing, and Additional Retro-Inspired Collectibles Based on Classic Arcade Sports Game Series Announced GlobeNewswire December 03, 2025 CHICAGO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Today, Digital Dreams Entertainment — a studio founded by developers behind SSX on Tour, FIFA

Rezolve Ai Accelerates Global Stablecoin Payments Rollout to Power the Next Wave of Agentic Commerce

Rezolve Ai Accelerates Global Stablecoin Payments Rollout to Power the Next Wave of Agentic Commerce More than $1B in stablecoin transactions processed as Rezolve extends payments capabilities across its growing enterprise customer base, accelerated by the addition of Crownpeak GlobeNewswire December 03, 2025 NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV),

Garrett Motion Announces $250 Million Share Repurchase Program for 2026

Garrett Motion Announces $250 Million Share Repurchase Program for 2026 GlobeNewswire December 03, 2025 PLYMOUTH, Mich. and ROLLE, Switzerland, Dec. 03, 2025 (GLOBE NEWSWIRE) — Garrett Motion Inc. (Nasdaq: GTX) (“Garrett” or the “Company”), a leading differentiated automotive technology provider, today announced that its Board of Directors has approved a new share repurchase program for

Interface Systems Forecasts 2026 Security Trends

Interface Systems Forecasts 2026 Security Trends Security landscape will be defined by proactive deterrence, human oversight, operational efficiency, and regulatory readiness GlobeNewswire December 03, 2025 St. Louis, MO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Interface Systems, a leading managed service provider delivering remote video monitoring, commercial security systems, business intelligence, and network to multi-location enterprises,

NowVertical Group to Participate in Bristol Capital Hosted Webinar on 10th December 2025

NowVertical Group to Participate in Bristol Capital Hosted Webinar on 10th December 2025 GlobeNewswire December 03, 2025 TORONTO, Dec. 03, 2025 (GLOBE NEWSWIRE) — NowVertical Group Inc. (TSXV: NOW) (“NOW” or the “Company”), a leading data and AI solutions provider, is pleased to announce its participation in an upcoming investor webinar hosted by Bristol Capital

BioCardia Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno

BioCardia Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno GlobeNewswire December 03, 2025 SUNNYVALE, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) — BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the election

Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8(R)

Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8(R) GlobeNewswire December 03, 2025 FDA recommended biomarker analyses show statistically significant reductions in NfL and GFAP in participants treated with CNM-Au8 Biomarker improvements are strongly associated with longer survival, reinforcing CNM-Au8's potential disease modifying activity Company has requested a Type C meeting

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval GlobeNewswire December 03, 2025 Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for 47% of all Medicare Advantage enrollees This latest approval will help enhance

Scroll to Top